C. McClung

407 total citations
25 papers, 270 citations indexed

About

C. McClung is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, C. McClung has authored 25 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in C. McClung's work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Mechanisms and Therapy (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). C. McClung is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Cancer Mechanisms and Therapy (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). C. McClung collaborates with scholars based in United States, South Korea and Lebanon. C. McClung's co-authors include Robert M. Wenham, Raffaele Baffa, Leonard G. Gomella, Andrea Vecchione, Paul D. Blumenthal, Ali Farooq, Johnathan M. Lancaster, Yin Xiong, Clement E. Furlong and Matthew S. Ripsch and has published in prestigious journals such as PLoS ONE, Neuroscience and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

C. McClung

20 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. McClung United States 11 89 64 58 46 37 25 270
Marcin Misiek Poland 11 60 0.7× 49 0.8× 49 0.8× 49 1.1× 21 0.6× 36 272
A. Onan Türkiye 9 82 0.9× 76 1.2× 58 1.0× 60 1.3× 33 0.9× 17 375
Till Kaltofen Germany 10 100 1.1× 25 0.4× 68 1.2× 29 0.6× 25 0.7× 26 292
Verónica Rojas Chile 7 119 1.3× 21 0.3× 61 1.1× 87 1.9× 27 0.7× 20 333
Cynae Johnson United States 4 118 1.3× 20 0.3× 74 1.3× 46 1.0× 50 1.4× 7 303
Caela Miller United States 9 86 1.0× 75 1.2× 51 0.9× 124 2.7× 35 0.9× 20 303
Jozef Višňovský Slovakia 12 152 1.7× 30 0.5× 81 1.4× 74 1.6× 22 0.6× 47 384
Annalisa Tancredi Italy 10 127 1.4× 26 0.4× 33 0.6× 60 1.3× 61 1.6× 19 411
Hiromasa Sasaki Japan 10 74 0.8× 131 2.0× 52 0.9× 55 1.2× 22 0.6× 33 322
Aljoša Mandić Serbia 9 56 0.6× 88 1.4× 86 1.5× 53 1.2× 12 0.3× 59 315

Countries citing papers authored by C. McClung

Since Specialization
Citations

This map shows the geographic impact of C. McClung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. McClung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. McClung more than expected).

Fields of papers citing papers by C. McClung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. McClung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. McClung. The network helps show where C. McClung may publish in the future.

Co-authorship network of co-authors of C. McClung

This figure shows the co-authorship network connecting the top 25 collaborators of C. McClung. A scholar is included among the top collaborators of C. McClung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. McClung. C. McClung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Susan M., Filippos Vingopoulos, Sahana Somasegar, et al.. (2025). Early experience and assessment of real-world toxicities with mirvetuximab soravtansine in a heavily pretreated patient cohort with ovarian cancer. Gynecologic Oncology Reports. 59. 101738–101738. 1 indexed citations
2.
Kuznicki, Michelle, C. McClung, Biwei Cao, et al.. (2022). Prognostic features of endometrial cancer metastasis to the central nervous system. PLoS ONE. 17(8). e0268794–e0268794. 2 indexed citations
3.
Kuznicki, Michelle, C. McClung, Sharon E. Robertson, et al.. (2020). Dual antibiotic prevention bundle is associated with decreased surgical site infections. International Journal of Gynecological Cancer. 30(9). 1411–1417. 2 indexed citations
4.
Kuznicki, Michelle, Susan Robertson, Silvia Martín, et al.. (2018). Microbiology of surgical site infections in gynecologic oncology population. Gynecologic Oncology. 149. 156–157. 1 indexed citations
5.
6.
Kang, Sokbom, Zachary Thompson, C. McClung, et al.. (2017). Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients with Endometrioid Endometrial Cancer. International Journal of Gynecological Cancer. 28(2). 260–266. 8 indexed citations
7.
Wenham, Robert M. & C. McClung. (2016). Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives. International Journal of Women s Health. 8. 59–59. 30 indexed citations
8.
McClung, C., et al.. (2016). Primary peritoneal carcinoma presenting as a Sister Mary Joseph's nodule: A case report and review of the literature. Gynecologic Oncology Reports. 17. 20–22. 1 indexed citations
9.
Xiong, Yin, Douglas C. Marchion, Forough Abbasi, et al.. (2015). Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance. Gynecologic Oncology. 140(2). 259–263. 16 indexed citations
10.
Marchion, Douglas C., Yin Xiong, C. McClung, et al.. (2015). Unique molecular portraits of ovarian cancer: Implications for prognostics and targeted therapeutics. Gynecologic Oncology. 137. 116–116.
11.
Ramírez, Ingrid, Douglas C. Marchion, Yin Xiong, et al.. (2015). Repurposing Artesunate, an anti-malarial, for ovarian cancer treatment: Mechanistic insights from cell line models. Gynecologic Oncology. 137. 207–207. 2 indexed citations
12.
Previs, Rebecca A., Kerri S. Bevis, Warner K. Huh, et al.. (2014). A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy. Gynecologic Oncology. 132(3). 531–536. 24 indexed citations
13.
Marchion, Douglas C., Yin Xiong, Ingrid Ramírez, et al.. (2014). The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest. Journal of Cancer Research and Clinical Oncology. 141(2). 237–242. 27 indexed citations
14.
McClung, C., et al.. (2013). Impact of Navigation on Knowledge and Attitudes About Clinical Trials Among Chinese Patients Undergoing Treatment for Breast and Gynecologic Cancers. Journal of Immigrant and Minority Health. 17(3). 976–979. 15 indexed citations
15.
Chan, John K., Warner K. Huh, C. McClung, et al.. (2012). Factors predictive of toxicity associated with bevacizumab and chemotherapy in recurrent ovarian cancer: A multi-institutional study. Gynecologic Oncology. 125. S69–S69. 2 indexed citations
16.
Foster, R G, Jae‐Young Jung, Ali Farooq, et al.. (2011). Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat. Neuroscience. 183. 230–237. 19 indexed citations
17.
Ferrara, Lauren, Manisha Gandhi, C. McClung, et al.. (2008). Chorionic villus sampling and the risk of adverse outcome in patients undergoing multifetal pregnancy reduction. American Journal of Obstetrics and Gynecology. 199(4). 408.e1–408.e4. 14 indexed citations
18.
Carty, Cara L., Patrick J. Heagerty, C. McClung, et al.. (2006). Inflammatory Response After Influenza Vaccination in Men With and Without Carotid Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 26(12). 2738–2744. 37 indexed citations
19.
Baffa, Raffaele, et al.. (2006). Molecular genetics of bladder cancer: targets for diagnosis and therapy.. PubMed. 25(2). 145–60. 44 indexed citations
20.
McKenzie, Michelle, et al.. (2005). Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program. Journal of Opioid Management. 1(3). 147–151. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcin Misiek Breakdown of academic impact, for papers by A. Onan Breakdown of academic impact, for papers by Till Kaltofen Breakdown of academic impact, for papers by Verónica Rojas Breakdown of academic impact, for papers by Cynae Johnson Breakdown of academic impact, for papers by Caela Miller Breakdown of academic impact, for papers by Jozef Višňovský Breakdown of academic impact, for papers by Annalisa Tancredi Breakdown of academic impact, for papers by Hiromasa Sasaki Breakdown of academic impact, for papers by Aljoša Mandić
Rankless by CCL
2026